ALB and chronic kidney disease: We recommend using a combination of ARB or ACEi with non-steroidal MRA—finerenone in CKD patients with T2D and with eGFR ≥ 25 mL/min/1.73 m2, serum potassium concentration ≤ 4.8 mmol/L, and urinary albumin/creatinine ratio ≥ 30 mg/g [1A].